C4 Therapeutics (CCCC) Net Margin Growth (1y) (2020 - 2026)
C4 Therapeutics (CCCC) Net Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | C4 Therapeutics | 460.17 Mn | 224.50 Mn | - | -8,247.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,247.00 |
| Dec 31, 2025 | 48,295.00 |
| Sep 30, 2025 | -12,586.00 |
| Jun 30, 2025 | -25,504.00 |
| Mar 31, 2025 | 56,957.00 |
| Dec 31, 2024 | 39,802.00 |
| Sep 30, 2024 | 8,363.00 |
| Jun 30, 2024 | 120,086.00 |
| Mar 31, 2024 | -799.00 |
| Dec 31, 2023 | 23,707.00 |
| Sep 30, 2023 | 22,898.00 |
| Jun 30, 2023 | -41,832.00 |
| Mar 31, 2023 | -51,213.00 |
| Dec 31, 2022 | -122,492.00 |
| Sep 30, 2022 | -18,278.00 |
| Jun 30, 2022 | -69,924.00 |
| Mar 31, 2022 | -13,072.00 |
| Dec 31, 2021 | 6,038.00 |
| Sep 30, 2021 | 2,981.00 |
| Jun 30, 2021 | -8,917.00 |